• Profile
Close

Efficacy and safety of topical JTE-052, a Janus kinase inhibitor, in Japanese adult patients with moderate-to-severe atopic dermatitis: A phase 2, multi-centre, randomised, vehicle-controlled clinical study

British Journal of Dermatology Oct 02, 2017

Nakagawa H, et al. - This trial substantiated the efficacy and safety of JTE-052 ointment in Japanese adult patients with atopic dermatitis (AD). The findings brought to light a rapid and significant improvement in the clinical signs and symptoms of such patients through the topical JTE-052 application. It demonstrated a favourable safety profile. Hence, topical JTE-052 served as a promising therapeutic option for AD.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay